2015 Press Releases

DATETITLE 
February 05, 2016POZEN And Tribute Combine To Create Aralez Pharmaceuticals Inc.Printer Friendly Version
February 02, 2016POZEN Inc. Announces Stockholder Approval of its Transaction with Tribute Pharmaceuticals Canada Inc.Printer Friendly Version
December 28, 2015POZEN Announces Effectiveness Of Aralez Registration Statement On Form S-4 And Provides Update On Key Milestones For 2016Printer Friendly Version
December 07, 2015POZEN And Tribute Announce Plan To Proceed With Merger To Form Aralez PharmaceuticalsPrinter Friendly Version
November 23, 2015POZEN And Tribute Provide Update On Pending Combination TransactionsPrinter Friendly Version
November 09, 2015POZEN Reports Third Quarter 2015 ResultsPrinter Friendly Version
November 06, 2015POZEN and Tribute Announce Effectiveness of Registration Statement on Form S-4Printer Friendly Version
October 26, 2015POZEN Inc. to Announce Third Quarter 2015 Results on November 9, 2015Printer Friendly Version
September 15, 2015POZEN to Present at the Ladenburg Thalmann Healthcare ConferencePrinter Friendly Version
September 14, 2015POZEN Appoints James P. Tursi, M.D. Chief Medical OfficerPrinter Friendly Version
August 10, 2015POZEN Reports Second Quarter 2015 ResultsPrinter Friendly Version
July 27, 2015POZEN Announces August 10th Webcast of Second Quarter 2015 ResultsPrinter Friendly Version
July 27, 2015POZEN Appoints Scott Charles Senior Vice President of FinancePrinter Friendly Version
June 22, 2015POZEN Announces Key Leadership AdditionsPrinter Friendly Version
June 08, 2015POZEN Announces Strategic Acquisition of Tribute and Growth Capital Commitment from Leading Healthcare SponsorsPrinter Friendly Version
June 02, 2015POZEN Forms an Irish Subsidiary and Enters into an Intangible Property Transfer ArrangementPrinter Friendly Version
June 01, 2015POZEN Announces Retirement of Founder, Chairman and CEO Dr. John R. Plachetka; Adrian Adams Named as CEOPrinter Friendly Version
May 08, 2015POZEN Reports First Quarter 2015 ResultsPrinter Friendly Version
May 04, 2015POZEN Announces May 8th Webcast of First Quarter 2015 ResultsPrinter Friendly Version
March 09, 2015POZEN Reports Fourth Quarter and Year End 2014 ResultsPrinter Friendly Version
March 04, 2015POZEN Announces March 9th Webcast of Fourth Quarter and Year End 2014 ResultsPrinter Friendly Version
February 04, 2015POZEN Announces Issuance of VIMOVO® Related Patent by the United States Patent and Trademark OfficePrinter Friendly Version

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.